You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
金斯瑞(01548.HK):高瓴资本入股传奇生物及认购其认股权证已完成
格隆汇 05-23 19:04

格隆汇5月23日丨金斯瑞生物科技(01548.HK)公布,2021年5月14日公告披露,内容有关(其中包括)购买股份及有关购买事项的视作出售传奇生物股权,即传奇生物同意发行及出售而买方LGN Holdings Limited同意购买合共2080.985万股传奇股份,总代价为3亿美元;及向买方发行传奇认股权证,可向传奇生物认购及购买最多合共1000万股传奇股份,总行使价为2亿美元。

董事会宣布,认购协议的所有条件已达成,完成已于2021年5月21日(交易时段后,香港时间)发生。完成后,买方持有2080.985万股传奇股份与认购传奇股份的传奇认股权证。

传奇完成及悉数行使传奇认股权证后传奇生物的股权架构载列如下,并取代该公告中的股权架构:

LGN Holdings Limited为根据开曼群岛法律注册成立的获豁免有限公司,其唯一投资管理人为高瓴资本管理有限公司。

高瓴资本成立于2005年,是一家由投资专业人士和营运行政人员组成的环球企业,专注于建立和投资于实现可持续增长的高品质商业特许经营机构。其独立的专有研究和行业专长,结合世界一流的运营和管理能力,是高瓴资本投资方式的关键。高瓴资本与卓越的企业家和管理团队合作创造价值,尤其重视于创新和技术转型。高瓴资本于不同股权投资阶段投资于医疗保健、消费、TMT、先进制造业、金融和商业服务行业的企业。高瓴资本及其集团成员代表全球机构客户管理资产。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account